This HTML5 document contains 135 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/
n12http://dx.doi.org/10.1592/

Statements

Subject Item
wd:Q44657315
rdf:type
wikibase:Item
schema:description
artikull shkencor scienca artikolo научная статья vitskapeleg artikkel 2009年学术文章 artigo científico บทความทางวิทยาศาสตร์ articolo scientifico জুন ২০০৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2009年學術文章 2009年學術文章 2009年学术文章 مقالة علمية نشرت في يونيو 2009 наукова стаття, опублікована в червні 2009 2009 nî lūn-bûn 2009年学术文章 scientific article published in June 2009 2009年学术文章 vetenskaplig artikel artikel ilmiah artigo científico tieteellinen artikkeli научни чланак wetenschappelijk artikel научни чланак научна статия 2009年學術文章 2009年の論文 vedecký článok wissenschaftlicher Artikel 2009年學術文章 artículo científico publicado en 2009 artículu científicu bài báo khoa học artikulong pang-agham מאמר מדעי article scientific 2009年学术文章 videnskabelig artikel artigo científico teaduslik artikkel article scientifique scientific article published in June 2009 bilimsel makale επιστημονικό άρθρο articol științific tudományos cikk vědecký článek 2009年學術文章 artykuł naukowy სამეცნიერო სტატია 2009년 논문 vitenskapelig artikkel мақолаи илмӣ naučni članak article científic scientific article published in June 2009 2009年学术文章
p:P577
wds:Q44657315-BBD9914B-748C-4AC7-808A-45E6CEC2ED18
wdt:P577
2009-06-01T00:00:00Z
p:P407
wds:Q44657315-95010514-6662-413B-9A27-D387128EADFE
wdt:P407
wd:Q1860
p:P2860
wds:Q44657315-F3A59D44-FBCC-40FB-AA06-2C0DF97C04C7 wds:Q44657315-F621867F-903F-411A-9431-F272616B5D5B wds:Q44657315-7E782F38-EFEB-4648-8D25-AAA60005B6DD wds:Q44657315-842E3560-674B-4F14-8ED6-2FB5EEC2788C wds:Q44657315-A1E4FF83-B1D7-4DA7-B7CA-8A6075784133 wds:Q44657315-C02F1F03-2C33-48EE-B3FF-52AE53EE9ED2 wds:Q44657315-DB831A46-1885-43AB-8336-628B7C09B62C wds:Q44657315-E10FC4BF-F626-4C53-B982-1242138C0816 wds:Q44657315-E7D3C406-0939-4900-85BF-AB521643E6C4 wds:Q44657315-13C2F70C-CD38-4F09-A164-4BFCB510F664 wds:Q44657315-3AFEF2A8-EDD1-4D94-850A-BEFA0B787141 wds:Q44657315-5CA87D64-C86D-42A7-B005-829AAFD5B8DA wds:Q44657315-6C51C7A2-1615-4E05-BBFA-9FF213640835 wds:Q44657315-7379D32F-31C3-4B5D-9DEE-D41B7115B4BD
wdt:P2860
wd:Q47382989 wd:Q51826453 wd:Q28194111 wd:Q46537869 wd:Q49168151 wd:Q34350556 wd:Q51745125 wd:Q36603232 wd:Q29615603 wd:Q35769983 wd:Q44139059 wd:Q44507061 wd:Q57243488 wd:Q47438826
p:P2093
wds:Q44657315-466BF945-F822-4864-B5C4-3D8F58904CEB wds:Q44657315-2657D549-FA13-4440-AA16-9F7992EB64F7 wds:Q44657315-1FB815BB-D763-4ACC-825F-A311D8DD592F wds:Q44657315-7BC9634E-35AC-4098-BC8C-F76F66093740 wds:Q44657315-9DB5BB7B-8BEC-4A9D-8F94-5E08A1379601
wdt:P2093
Karen P Alexander Charles V Pollack W Brian Gibler Fang-Shu Ou Sarah A Spinler
rdfs:label
Weight-based dosing of enoxaparin in obese patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE initiative Weight-based dosing of enoxaparin in obese patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE initiative
skos:prefLabel
Weight-based dosing of enoxaparin in obese patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE initiative Weight-based dosing of enoxaparin in obese patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE initiative
schema:name
Weight-based dosing of enoxaparin in obese patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE initiative Weight-based dosing of enoxaparin in obese patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE initiative
p:P50
wds:Q44657315-BECC530F-7A58-4B77-BCBE-ECA668897335 wds:Q44657315-731AB873-6324-4759-91D6-B78EA44F972F wds:Q44657315-2DE53D96-F47B-4DA8-8D45-9073F0057688
wdt:P50
wd:Q64684757 wd:Q60697402 wd:Q63021326
p:P1476
wds:Q44657315-7DDEFC81-02C1-4262-91A6-C3F164F8BDC6
wdt:P1476
Weight-based dosing of enoxaparin in obese patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE initiative
p:P304
wds:Q44657315-6C27811D-24CC-4577-9B63-29695D921F91
wdt:P304
631-638
p:P31
wds:Q44657315-BE2A2764-7B1E-493B-9C0F-34DA4309A67F
wdt:P31
wd:Q13442814
p:P921
wds:Q44657315-D0F263BF-F4D4-4B51-BBDF-0BE7F85142E0 wds:Q44657315-9A2EEA74-0F50-46A5-9978-44576E418A44
wdt:P921
wd:Q12174 wd:Q266018
p:P698
wds:Q44657315-53AC0B03-82AF-4F58-B845-22B9E29CB375
wdtn:P698
n11:19476416
wdt:P698
19476416
p:P1433
wds:Q44657315-E6582A7B-7547-4935-8639-26AF33D991C1
wdt:P1433
wd:Q7180800
p:P433
wds:Q44657315-C8F3B41F-96DF-4378-AF5F-2D073C2A63C9
p:P478
wds:Q44657315-2443CF3B-D172-4F6A-A0EE-B75EB59C1531
wdt:P433
6
wdt:P478
29
p:P356
wds:Q44657315-09827164-1363-4F96-9DC2-FA03A9782E65
wdtn:P356
n12:PHCO.29.6.631
wdt:P356
10.1592/PHCO.29.6.631